化合物が臨床前研究において顕著な将来性を示す場合、ヒト患者における安全性および有効性を評価するために臨床試験に入る可能性がある。臨床試験は多くの段階に関連しており,厳しい試験により癌治療としての有効性を確保している。
化学原料を購入する必要がある場合は、 要求情報を送信してください最新の見積りを入手してください。
5,6-bis[(acetyloxy)methyl]-7-oxabicyclo[2.2.1]hept-5-ene-2,3-diyl diacetate
Benzamide, N-(2-hydroxy-3-phenoxypropyl)-4-nitro-
5'-deoxy-5'-(4-nitrobenzamido)thymidine
C26H17ClN6
C20H21Cl2N3O2S
C21H21NO9S
C18H19NOS2
ピリジン
N,N'-(1,4-phenylene)bis(2-fluorobenzenesulfonamide)
2-(5-Bromo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene
Glycine, N-[(3,5-difluorophenyl)acetyl]-L-alanyl-2-phenyl-, (2S)-
2-((benzoyloxy)methyl)-5-(4,5-diamino-2-oxopyrimidin-1(2H)yl)tetrahydrofuran-3,4-diyl dibenzoate
{3-[(4-benzoylpiperazin-1-yl)(oxo)acetyl]-4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-1-yl}methyl dihydrogen phosphate
2-[4-(4-Ethoxy-phenyl)-butyl]-isoindole-1,3-dione
シリカゲル
2-Propanol, 1-amino-3-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-, (S)-
VK-28
3-Heptanone, 1,7-bis(4-hydroxy-3-methoxyphenyl)-
methyl 3-(4-((2-chloropyridin-4-yl)ethynyl)phenyl)propanoate
dehydroandrographolide
dibenzyl N-(phosphonoacetyl)aspartate
3-{4-[2-amino-6-(4-pyrimidin-2-ylpiperazin-1-yl)pyrimidin-4-yloxy]phenyl}-2-methyl-2-phenoxypropionic acid
4-nitro-3-(3-bromophenylamino)pyridine N-oxide
3-(4-chlorophenyl)-1-(4-nitrophenyl)-1H-pyrazole-4-carbaldehyde
(1-(5-chloro-2-methoxyphenyl)-1H-1,2,3-triazol-4-yl)(phenyl)methanone
2-benzyloxycarbonylamino-3-iodo-propionic acid tert-butyl ester
6-{2-[2,3-dichloro-4-(2-methylenebutyryl)phenoxy]acetylamino}hexanoic acid
TRANS-2-(4-METHYLPHENYL)VINYLBORONIC AC&
C38H54O10
C30H42N4O6
4-(4-((2-fluorophenyl)(hydroxyimino)methyl)pyrimidin-2-ylamino)benzonitrile
2-(acetyloxy)-N,N-dimethyl-N-[(trimethylsilyl)methyl]ethanaminium iodide
Choline
2'-fluoro-4-nitro-biphenyl-2-carboxylic acid
methyl acetamido-2,6-anhydro-3,5-dideoxy-9-p-toluenesulfonyl-D-glycero-D-galactonon-2-enonate
(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-((R)-1-(4-dimethylaminobenzyl)pyrrolidin-3-yl)-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
5
11
3
2-tert-butoxycarbonylamino-3-(1H-indol-3-yl)-propionic acid 2-oxo-1,2-diphenyl-ethyl ester
C24H25FN4
C23H17N5O
5-[4-(3-ethyl-3H-imidazo[4,5-b]pyridin-2-ylmethoxy)benzyl]-3-triphenylmethylthiazolidine-2,4-dione
ethyl (8R,9S)-8-[[(1R)-1-phenylethyl]amino]-1,4-dioxaspiro[4.5]decane-9-carboxylate
methyl 3-{N-(1-butyl)-2-chloro-4-{[3-(2,6-dichlorophenyl)-5-isopropylisoxazol-4-yl]methoxy}benzamido}benzoate
4-(ジメチルアミノ)ピリジン
AMINES
4-(5-phenyl-1H-1,2,3-triazol-1-yl)benzenesulfonamide
(2R)-2-bromo-4-methylpentanoic acid t-butyl ester
C26H24N2O6S4
5,10,15,20-tetra(n-hexyl)phorphyrin
C17H13N3O4S3
(2-fluoro-5-nitrophenyl)-N-(4-methoxybenzyl)-methanamine
5-((tert-butoxycarbonyl)(3,5-dimethyladamantan-1-yl)amino)pentyl 4-methylbenzenesulfonate
ジクロロメタン(別名塩化メチレン)
テトラヒドロフラン
acetonitrile